Eisai Pricing For Lecanemab Reflects Concern With Medicare ‘Sustainability,’ ‘Giving Back,’ Firm Says

 
• By Cathy Kelly
  
Lecanemab and Medicare
A Public Spirited Approach To Drug Pricing? • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Market Access

More from Pink Sheet